ArticleCritical care (London, England)2026
Time-to-vasopressors and clinical outcome by level of diastolic blood pressure and pulse pressure in patients with septic shock: a retrospective analysis of prospective multicenter cohort study.
Article in Critical care (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Pulse Pressure as a Predictor of Increased 30-Day Mortality in Acute Pulmonary Embolism.Academic emergency medicine : official journal of the Society for Academic Emergency Medicine · 2026Article
- Association between baseline pulse pressure and prognosis in critically ill patients: a retrospective cohort study.Scientific reports · 2026Article
- Baseline alignment and resuscitation exposure in hemodynamic phenotyping of septic shock.Critical care (London, England) · 2026Article
- Early norepinephrine in septic shock: are we treating physiology or system efficiency?Critical care (London, England) · 2026Article
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
10 authors.
Funding
Abstract
backgroundThe optimal timing of vasopressor initiation in septic shock remains uncertain, and mixed trial results may reflect unmeasured hemodynamic heterogeneity. We hypothesized that the association between early norepinephrine and mortality differs by bedside hemodynamic phenotype, as characterized by diastolic blood pressure (DBP) and pulse pressure (PP).
methodsWe conducted a retrospective analysis of prospectively collected data from a national sepsis registry (2019–2024). Adults with septic shock presenting to emergency departments were included. Time-to-vasopressor was defined as the time from triage to norepinephrine initiation; restricted cubic splines supported an a priori classification of “early” use as ≤ 25 min. The primary outcome was in-hospital mortality. Patients were stratified by pre-vasopressor DBP (< 50 vs. ≥ 50 mmHg) and, secondarily, by PP (< 25 vs. ≥ 25 mmHg). Multivariable models adjusted for demographics, comorbidities, illness severity (SOFA), three-hour sepsis bundle completion, and mechanical ventilation. Sensitivity analyses explored alternative DBP thresholds (< 40, < 44 mmHg), and subgroup analyses assessed effect consistency.
resultsAmong 1,104 patients, early norepinephrine was associated with lower mortality only in those with low DBP; there was no mortality benefit when DBP was ≥ 50 mmHg. Mortality associations were stronger at more extreme diastolic hypotension thresholds (< 40 and < 44 mmHg). Hemodynamic phenotyping with PP further refined risk: within the low-DBP group, a wide PP (≥ 25 mmHg) was associated with the most pronounced survival association from immediate vasopressors, whereas a narrow PP showed no clear benefit. Results were directionally consistent across sensitivity and subgroup analyses.
conclusionsThe relationship between vasopressor timing and outcomes in septic shock is hemodynamic phenotype dependent. Early norepinephrine appears beneficial when DBP is markedly low, particularly with wide PP, and less critical when DBP is preserved or PP is narrow. Simple bedside measurements (DBP and PP) can guide individualized resuscitation, helping clinicians decide whether to initiate vasopressors or initially emphasize preload or inotropy.
trial registrationNot applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.